BindingDB logo
myBDB logout

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25677656 7 A novel molecule with notable activity against multi-drug resistant tuberculosis.EBI University of Georgia
21030469 31 Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.EBI University of Minnesota
22822035 10 Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.EBI Chinese Academy of Sciences
21346002 5 Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.EBI Toyama Chemical Co., Ltd.
21177485 7 Glucuronidation of the red clover isoflavone irilone by liver microsomes from different species and human UDP-glucuronosyltransferases.EBI Max Rubner-Institute
23132334 28 In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.EBI GlaxoSmithKline
15781124 12 UDP-glucuronosyltransferases and clinical drug-drug interactions.EBI The University of British Columbia
30938524 21 Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.EBI TBA
30623649 13 Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.EBI Gwangju Institute of Science and Technology
29548573 14 Identification of second-generation P2X3 antagonists for treatment of pain.EBI Merck & Co.